Related Experiment Video
Updated: Aug 17, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
The Evolution of Hypertension Guidelines Over the Last 20+ Years: A Comprehensive Review
Endurance O Evbayekha1, Okelue E Okobi2,3, Tobechukwu Okobi4
1Internal Medicine, St. Luke's Hospital, Chesterfield, USA.
Insights
Hypertension guidelines have evolved significantly over 22 years, focusing on at-risk groups and personalized treatment based on disease stage and comorbidities, not ethnicity.
Area of Science:
- Cardiology
- Nephrology
- Neurology
Background:
- Hypertension is a primary modifiable risk factor for cardiovascular and cerebrovascular diseases.
- Guideline recommendations for hypertension management have undergone substantial evolution over the past two decades.
- This evolution reflects advancements in understanding and treating hypertension in diverse patient populations.
Purpose of the Study:
- To systematically review the literature on hypertension management guidelines published between 2000 and 2022.
- To identify key changes and trends in hypertension screening and treatment recommendations over a 22-year period.
- To analyze the factors influencing guideline evolution, particularly for specific patient subgroups.
Main Methods:
- A comprehensive literature search was conducted across PubMed, Embase, Google Scholar, and Cochrane databases.
- Keywords "hypertension" and "guidelines" were used with Boolean operators for article retrieval.
- Systematic screening of titles, abstracts, and full-text articles was performed to identify eligible publications, with 190 articles meeting inclusion criteria.
Main Results:
- Guideline evolution primarily focused on refining management thresholds for elderly patients and those with diabetic kidney disease, chronic kidney disease, and stroke.
- Current medication choices are increasingly guided by disease stage and comorbidities, shifting away from ethnicity-based criteria.
- Significant changes in hypertension management strategies have been observed over the 22-year study period.
Conclusions:
- Hypertension management guidelines have become more nuanced, incorporating patient-specific factors for improved care.
- The shift towards personalized medicine in hypertension treatment reflects a deeper understanding of the disease and its impact on various populations.
- Continued evaluation of guidelines is essential to adapt to new evidence and optimize patient outcomes.
Abstract:
Hypertension is the most common modifiable risk factor for cardiovascular and cerebrovascular diseases. In the last two decades, the guidelines have evolved tremendously from areas with no recommendations for screening or treatment to targeted recommendations for some at-risk groups. We sought to go through the literature that provided guidelines for the management of hypertension at any point in time over the last 22 years from 2000 to 2022. We searched four databases: PubMed, Embase, Google Scholar, and Cochrane, using specified search terms. The keywords used were "hypertension" and "guidelines." We combined them using the Boolean operators (AND, OR) and searched for articles. A total of 2461 publications were initially identified; 348 publications were excluded after screening for full-text availability. The full-text articles were further filtered based on title and abstract screening. Following this, a total of 1443 articles were excluded. The remaining 670 full-text articles were assessed for eligibility. Of the 670 full-text articles, 480 were excluded based on exclusion criteria, and following the full-text article screening, 190 articles met the final inclusion criteria. Most of these guideline evolutions concerned establishing and adjusting thresholds for the subgroups of the elderly population and patients with diabetic kidney disease, chronic kidney disease, and stroke. Furthermore, the medications of choice are now guided by the stage of disease, presence or absence of comorbidities, and other relevant information, as opposed to ethnicity, which was previously a heavy yardstick for medication choice.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications

